PacBio

PacBio develops a real-time sequencing system that monitors and analyzes single molecule biochemical reactions for the healthcare industry. Read more

Christian O. Henry's photo - President & CEO of PacBio

President & CEO

Christian O. Henry

CEO Approval Rating

98/100

Founded:

2004

Status:

PublicIndependent CompanyNASDAQPACB

PACBIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Oxford Nanopore is seen as one of PacBio's top competitors. Oxford Nanopore's headquarters is in London, England, and was founded in 2004. Like PacBio, Oxford Nanopore also works within the Biotechnology industry. Oxford Nanopore generates 73% of PacBio's revenue.

QIAGEN is one of PacBio's top rivals. QIAGEN was founded in 1984, and its headquarters is in Hilden, North Rhine-Westphalia. Like PacBio, QIAGEN also works within the Biotechnology field. QIAGEN has 5,209 more employees than PacBio.

Illumina is PacBio's #3 rival. Illumina is a Public company that was founded in 1998 in San Diego, California. Like PacBio, Illumina also competes in the Biotechnology sector. Compared to PacBio, Illumina has 7,399 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Vizgen a competitor of PacBio?

PacBio Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$92.3M

PacBio's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 3.5B. Over the last four quarters, PacBio's revenue has grown by 69.8%. Specifically, in Q1 2021's revenue was $29M; in Q4 2020, it was $27.1M; in Q3 2020, it was $19.1M; in Q2 2020, PacBio's revenue was $17.1M.

PacBio Acquisitions

No recent acquisitions found related to PacBio

PacBio Funding History

Since PacBio was founded in 2004, it has participated in 5 rounds of funding. In total PacBio has raised $438.5M. PacBio's last funding round was on Feb 2013 for a total of $20.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Post-IPO Debt
Feb 2013
$20.5M

Mohr Davidow Ventures

IPO
Oct 2010
$200M
-
Series E
Oct 2009
$68M
Series E
Jul 2008
$100M
Series D
Jan 2007
$50M

Since PacBio was founded in 2004, it has participated in 5 rounds of funding. In total PacBio has raised $438.5M. PacBio's last funding round was on Feb 2013 for a total of $20.5M

PacBio Investments

No recent investments found related to PacBio

PacBio News

April 30, 2021Markets Insider

Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results

MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDA... See more »
April 15, 2021MarketScreener

Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call

(marketscreener.com) MENLO PARK, Calif., April 15, 2021 -- Pacific Biosciences of California, Inc. wi... See more »
February 26, 2021Markets Insider

Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ... See more »
February 24, 2021BioSpace

Children's Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read... See more »
February 23, 2021Zacks

Pacific Biosciences' (PACB) Sequel II Gets Deployed by LabCorp

Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 v... See more »

PacBio Blogs

May 10, 2021PacBio Blog

Sequencing 101: DNA Extraction - Tips, Kits, & Protocols

Learn how to perform DNA extraction for optional results including what kits and protocols work well ... See more »
May 4, 2021PacBio Blog

Pandemic Preparedness: PacBio and Labcorp Team Up On a Global Pan-Pathogen Surveillance Network

A global pathogen surveillance network would save countless lives, and lessons learned from the curre... See more »
April 26, 2021PacBio Blog

New HiFi Sequencing Workflow and Software Update Streamlines Whole Genome Sequencing

Today we're pleased to announce the launch of a new HiFi Sequencing workflow along with a software up... See more »
April 22, 2021PacBio Blog

Conservation is For Life, Not Just For Earth Day

While COVID-19 has focused the attention of the scientific community on pathogen detection, surveilla... See more »
April 21, 2021PacBio Blog

SMRT Sequencing Detects Clinically Significant Repeat Changes In Triplet Expansion Disorders

Former SMRTGrant winner Stéphanie Tomé has published the results of her work using HiFi... See more »
April 8, 2021PacBio Blog

PacBio Sequencing Uncovers Large Deletions in RSV Vaccine Candidate Under Selective Pressure

With growing interest in viral sequencing and vaccine development, understanding how viruses adapt un... See more »
April 6, 2021PacBio Blog

SMRT Grant Winners - Collaboration Reaches New Heights in Global Science Challenge

Today we're pleased to announce the three winners of our 2020 HiFi for All - Collaborations SMRT Gran... See more »

PacBio Press Releases

January 29, 2021StreetInsider

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ... See more »
January 8, 2021GlobalNewswire

Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative

Seven new Sequel IIe Systems will support expanded generation of high-quality genomes for improving f... See more »
December 16, 2020GlobeNewswire

SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology

Presentation at the American Society for Microbiology NGS Conference highlights utility of PacBio's h... See more »
December 14, 2020GlobeNewswire

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research h... See more »
October 15, 2020GlobeNewswire

Children's Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease

Collaboration will utilize PacBio's highly accurate HiFi sequencing to solve rare pediatric genetic d... See more »
June 10, 2020GlobeNewswire

Pacific Biosciences Announces Planned Retirement of CEO, Dr. Michael Hunkapiller

Dr. Hunkapiller to retire by the end of 2020... See more »
May 20, 2020PR Newswire

Personal Genomics, Inc. Files Patent Infringement Complaint Against Pacific Biosciences of California, Inc. in China

HSINCHU, Taiwan, May 20, 2020 /PRNewswire/ -- Personal Genomics Taiwan, Inc. ("PGI"), today announced... See more »

PacBio Videos

Social Media

PacBio Headquarters

1305 O'Brien Drive

Menlo Park, California94025

650-521-8000

Driving Directions »

Trending Companies

PacBio Summary

ABOUT

Overview

PacBio develops a real-time sequencing system that monitors and analyzes single molecule biochemical reactions for the healthcare industry. PacBio was founded in 2004. PacBio's headquarters is located in Menlo Park, California, USA 94025. It has raise...

CEO

PacBio's President & CEO, Christian O. Henry, currently has an approval rating of 98%. PacBio's primary competitors are Oxford Nanopore, QIAGEN & Illumina.

Website

pacb.com

Frequently Asked Questions about PacBio

  1. When was PacBio founded?

    PacBio was founded in 2004
  2. Who is PacBio's CEO?

    PacBio's CEO is Christian O. Henry
  3. How much revenue does PacBio generate?

    PacBio generates $92.3M in revenue
  4. How much funding does PacBio have?

    PacBio has historically raised $438.5M in funding
  1. Where is PacBio's headquarters?

    PacBio's headquarters is in Menlo Park California, USA
  2. How many employees does PacBio have?

    PacBio has 401 employees
  3. What sector does PacBio operate in?

    PacBio is in Biotechnology
  4. Who are PacBio's competitors?

    PacBio's top competitors are Oxford Nanopore, QIAGEN, Illumina